An Exploratory Critical Review on TNF-α as a Potential Inflammatory Biomarker Responsive to Dietary Intervention with Bioactive Foods and Derived Products

Abstract

This review collects and critically examines data on the levels of tumour necrosis factor-alpha (TNF-α) in lean, overweight and obese subjects, and the effects of intervention with different foods and food products containing bioactive constituents in overweight/obese individuals. We additionally explore the influence of different single nucleotide polymorphisms (SNPs) on TNF-α levels and compare the response to food products with that to some anti-obesity drugs. Our aim was to provide an overview of the variability, consistency, and magnitude of the reported effects of dietary factors on TNF-α, and to envisage the reliability of measuring changes in the levels of this cytokine as a biomarker responsive to food intervention in association with the reduction in body weight. Regarding the circulating levels of TNF-α, we report: (i) a large intra-group variability, with most coefficients of variation (CV%) values being ³30% and, in many cases, >100%; (ii) a large between-studies variability, with baseline TNF-α values ranging from <1.0 up to several hundred pg/mL; (iii) highly variable effects of the different dietary approaches with both statistically significant and not significant decreases or increases of the protein, and the absolute effect size varying from <0.1 pg/mL up to ≈50 pg/mL. Within this scenario of variability, it was not possible to discern clear differentiating limits in TNF-α between lean, overweight, and obese individuals or a distinct downregulatory effect on this cytokine by any of the different dietary approaches reviewed, i.e., polyunsaturated fatty acids (PUFAs), Vitamin-D (VitD), mixed (micro)nutrients, (poly)phenols or other phytochemicals. Further, there was not a clear relationship between the TNF-α responses and body weight changes. We found similarities between dietary and pharmacological treatments in terms of variability and limited evidence of the TNF-α response. Different factors that contribute to this variability are discussed and some specific recommendations are proposed to reinforce the need to improve future studies looking at this cytokine as a potential biomarker of response to dietary approaches.

The Effect of High-Intensity Interval Exercise on Short-Term Glycaemic Control, Serum Level of Key Mediator in Hypoxia and Pro-Inflammatory Cytokines in Patients with Type 1 Diabetes—An Exploratory Case Study

“…TNF-α is a biomarker of systemic inflammation [3][4][5]; therefore, the fact that its level was lower in the T1D group could indicate no chronic inflammation. Nevertheless, this observation is based on the mean value and 22.2% of T1D participants (n = 2) were found with resting TNF-α of >50.0 pg/mL, which indicated a rather high level of inflammation when compared with the normal range of the cytokine observed in individuals without inflammatory diseases [104,105]. TNF-α is amongst the main pro-inflammatory cytokines implicated in the inflammation of the pancreatic beta cells [106]; hence, its elevated level is to be expected in T1D patients.…”

Chia Phenolic Extract Appear to Improve Small Intestinal Functionality, Morphology, Bacterial Populations, and Inflammation Biomarkers In Vivo (Gallus gallus)

“…TNF-α is an activator of the production of different cytokines, promoting a pro-inflammatory state. In general, long-term elevated TNF-α levels are associated with conditions such as inflammatory bowel disease, and lowering the levels of this cytokine is generally considered to have a beneficial anti-inflammatory effect [ 36 , 37 , 38 ]. A previous study characterized the chia phenolic extract and found that the main phenolic compounds in the extract were rosmarinic acid, danshensu glycoside, ferulic acid, and caffeic acid [ 23 ].…”

Phytochemicals and Vitamin D for a Healthy Life and Prevention of Diseases

“…There has been intriguing genetic research showing the benefit of vitamin D and phytochemicals in the remission of inflammatory bowel disease [89]. In a dietary intervention study, they were found to downregulate the level of TNF-α, an important factor in chronic inflammation [90].…”